# The Role of GIP and GLP-2 in Postprandial Splanchnic Blood Flow Distribution and Metabolism

> **NCT05391581** · NA · COMPLETED · sponsor: **University of Copenhagen** · enrollment: 10 (actual)

## Conditions studied

- Blood Flow

## Interventions

- **OTHER:** GIPR antagonist / study tool
- **OTHER:** GLP-2R antagonist / study tool
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05391581
- **Lead sponsor:** University of Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-13
- **Primary completion:** 2023-02-07
- **Final completion:** 2023-02-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-12-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05391581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05391581, "The Role of GIP and GLP-2 in Postprandial Splanchnic Blood Flow Distribution and Metabolism". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05391581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*